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hMutSb, a heterodimer of hMSH2 and hMSH3, binds to
insertion/deletion loops in DNA
Fabio Palombo*, Ingram Iaccarino*, Eiitsu Nakajima†, Miyoko Ikejima†, 
Takashi Shimada† and Josef Jiricny*
In human cells, mismatch recognition is mediated by a
heterodimeric complex, hMutSa, comprised of two
members of the MutS homolog (MSH) family of proteins,
hMSH2 and GTBP [1,2]. Correspondingly, tumour-derived
cell lines defective in hMSH2 and GTBP have a mutator
phenotype [3,4], and extracts prepared from these cells
lack mismatch-binding activity [1]. However, although
hMSH2 mutant cell lines showed considerable
microsatellite instability in tracts of mononucleotide and
dinucleotide repeats [4,5], only mononucleotide repeats
were somewhat unstable in GTBP mutants [4,6]. These
findings, together with data showing that extracts of
cells lacking GTBP are partially proficient in the repair of
two-nucleotide loops [2], suggested that loop repair can
be GTBP-independent. We show here that hMSH2 can
also heterodimerize with a third human MSH family
member, hMSH3, and that this complex, hMutSb, binds
loops of one to four extrahelical bases. Our data further
suggest that hMSH3 and GTBP are redundant in loop
repair, and help explain why only mutations in hMSH2,
and not in GTBP or hMSH3, segregate with hereditary
non-polyposis colorectal cancer (HNPCC) [7].
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Results and discussion
The phenotypic differences between GTBP and hMSH2
mutants were partially explained by the biochemical exper-
iments of Drummond et al. [2], who showed that LoVo cell
extracts, which lack hMSH2, were unable to process a G/T
mismatch or a loop of two extrahelical nucleotides. By con-
trast, DLDl/HCT15 extracts, which lack GTBP, could par-
tially process a dinucleotide (TG) loop. Although the
deficiency in base–base mismatch and loop repair could be
complemented by adding purified hMutSa, which directly
demonstrated that the hMSH2–GTBP heterodimer also
functions in loop repair, these results implied that the
repair of loops of two or more nucleotides absolutely
requires hMSH2, but not GTBP. We therefore considered
the possibility that hMSH2 alone might be the loop-
binding factor, as reported previously [8,9]. We could
reproduce these latter experiments in our laboratory, using
protein purified from a Baculovirus expression system.
However, in our hands, mismatch-binding activity was only
seen in the absence of non-specific competitor DNA, and
at a protein concentration around 100 nM (data not shown),
which was approximately two orders of magnitude greater
than that of hMutSa, even under experimental conditions
where non-specific competitor was present (see below).
We therefore set out to test the hypothesis [10] that loop
recognition is mediated by a factor distinct from hMutSa,
most probably a complex between hMSH2 and a second, as
yet unknown, protein. What could be this missing partner
of hMSH2? We turned our attention to the first described
human MutS homolog, hMSH3, also known as DUP1 [11]
or MRP1 [12], as recent data showed that mutation of
MSH3, which encodes the Saccharomyces cerevisiae homolog
of hMSH3, results in a limited microsatellite instability [13]
and a weak mutator phenotype [14]. We investigated the
ability of hMSH3 to interact with hMSH2, and studied the
affinity of the resulting complex for substrates containing
loops and base–base mismatches. We also compared the
substrate specificity of the hMSH3–hMSH2 complex with
that of hMutSa.
The putative hMSH3-containing loop-binding factor is not
very abundant, as demonstrated by the fact that  hMSH3
was undetectable in western blots of human cell extracts
probed with polyclonal rabbit or mouse anti-hMSH3 anti-
sera (data not shown). This might explain why no activity
able to specifically bind to loops of two or more nucleotides
Figure 1
Purification of hMutSa and hMutSb from Sf9 cells co-infected with
Baculovirus vectors expressing hMSH2 and GTBP, or hMSH2 and
hMSH3, respectively. The figure shows a Coomassie-stained denaturing
7.5 % SDS–polyacrylamide gel; M, molecular weight standards.
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has been detected by band-shift assays using unfraction-
ated cell extracts lacking hMutSa. We therefore decided
to express hMSH3, GTBP and hMSH2, either alone or in
combination, in the Baculovirus system and to study the
substrate specificity of the purified individual proteins
and the heterodimeric complexes. Expression of bac-
ulovirus-expressed hMSH3 in Sf9 cells yielded predomi-
nantly insoluble protein aggregates (data not shown).
However, co-infection with viral vectors encoding hMSH2
and hMSH3 resulted in the production of soluble proteins,
which co-purified by chromatography on heparin–
Sepharose as an equimolar mixture of polypeptides of
approximate molecular weights of 107 and 131 kDa (Fig.
1). This corresponded very well with the expected sizes of
hMSH2 (105 kDa) and hMSH3 (127 kDa) calculated from
their amino-acid compositions. A similar purification strat-
egy, using extracts of Sf9 cells co-infected with vectors
expressing GTBP and hMSH2, yielded the hMutSa het-
erodimer (Fig. 1), composed of GTBP (apparent and cal-
culated molecular weights 167 kDa and 153 kDa,
respectively) and hMSH2.
The finding that hMSH2 and hMSH3 co-purified in a
similar way to hMutSa [2], eluting from single-stranded
DNA–Sepharose with ATP, suggested that the two pro-
teins also exist in a complex. Two additional experiments
supported this prediction: first, polyclonal anti-hMSH2
antiserum immunoprecipitated hMSH3 from extracts of
Sf9 cells that co-expressed hMSH3 and hMSH2 (Fig. 2,
lane 5), but not from extracts from cells expressing
hMSH3 only (Fig. 2, lane 4); second, gel-filtration experi-
ments similar to those described previously [2] showed
that hMutSa and hMSH2–hMSH3 both eluted with a
similar retention time from a S-200 Sephacryl FPLC
column, with an approximate molecular weight of 250 kDa
(data not shown). As hMSH2–hMSH3 and hMutSa
showed similar ATP-sensitive DNA binding in band-shift
assays ([2,15]; data not shown) we named it hMutSb.
We next examined the ability of the two heterodimeric
complexes to bind to substrates containing mismatches 
or extrahelical nucleotides. Figure 3 shows that purified
Baculovirus-expressed hMutSa had the highest affinity for
substrates containing a G/T mispair and a single extraheli-
cal thymine (see also [2]), whereas loops of two, three or
four nucleotides were bound with a significantly lower
efficiency in the band-shift assay. In contrast, purified
hMutSb had a clear preference for loops of two or more
nucleotides (Fig. 3; substrates are shown in Fig. 4b).
The efficiency of loop recognition by the two factors
seemed to vary according to the extrahelical nucleotides
and their flanking sequences. Thus, although the affinity
of hMutSb for the two-nucleotide GT loop was about five
times higher than that of hMutSa, the GT loop in sub-
strate I was bound better by hMutSa (Fig. 4). Interest-
ingly, the substrates that were bound poorly by one factor
were generally better substrates for the other heterodimer,
which further implies that hMutSa and hMutSb are func-
tionally redundant, at least to some extent [2].
These preliminary studies of substrate specificity show
that hMutSa and hMutSb complement one another in
loop recognition. As its name implies, postreplicative mis-
match repair must address all errors of DNA replication,
be they base–base mismatches or loops. It seems likely
that, under normal circumstances, hMutSa plays the major
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Figure 2
Co-immunoprecipitation of hMSH2 and hMSH3. Lanes 1–3, total extracts
of Sf9 cells (6 mg protein) infected with Baculovirus vectors expressing
hMSH3 (lane 1), hMSH3 and hMSH2 (lane 2) and hMSH2 (lane 3). Lanes
4–6, immunoprecipitation of the same extracts with rabbit polyclonal anti-
hMSH2 antiserum. Lane 7, 7 ng purified hMutSb.
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Figure 3
Binding of hMutSa and hMutSb to oligonucleotide duplexes containing
mismatched base pairs or extrahelical nucleotides. The figure is an
autoradiogram of a 6 % native polyacrylamide gel, run in TAE buffer.
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role in recognizing both of these types of replication error.
The results of Drummond et al. [2] showed that hMutSa
is functional in two-nucleotide loop repair, as shown by
the fact that addition of the purified heterodimer to
extracts of mismatch repair-deficient LoVo cells restores
the repair of a G/T mismatch and a two-nucleotide loop.
Their experiments also showed that hMutSa is not essen-
tial for loop repair, as extracts from GTBP mutants were
partially proficient in loop repair [2]. This implied that
loop repair can also be mediated by a GTBP-independent
factor and we anticipated that this factor could be
hMutSb. This hypothesis seems to be correct, as our pre-
liminary data show that purified hMutSb can restore loop
repair (but not base–base mismatch repair) to LoVo
extracts (J. Drummond, P. Modrich, F.P., I.I., E.N., M.I.,
T.S. and J.J., unpublished observations).
Does hMutSb really play a role in loop repair and
microsatellite instability? As MSH3 is involved in mis-
match correction in S. cerevisiae [13,14,16,17], it seems rea-
sonable to infer that hMSH3 will play an analogous role in
mammals. Although our results represent the first experi-
mental evidence in support of this hypothesis, more data
may be forthcoming shortly, as recent RT-PCR analysis of
bone marrow cells from patients with haematological
malignancies identified individuals with highly variable
levels of hMSH3 mRNA [12]. Although the results with
yeast msh3 mutants predict that cells lacking hMSH3 will
not have strong mutator phenotypes, it could be postulated
that dysregulation of MSH3 transcription could have dele-
terious effects on mismatch repair. Thus, overexpression of
hMSH3 might significantly alter the relative concentra-
tions of hMutSa and hMutsb by sequestering hMSH2
preferentially in the latter heterodimer. As hMutSb does
not bind to base–base mispairs, one would predict that
these cells would be similar to those lacking GTBP, in
demonstrating low or negligible microsatellite instability
but a strong mutator phenotype. It is tempting to speculate
that such clones might be generated in vivo in cancer
patients treated with some anti-metabolites; for example,
methotrexate treatment often leads to the amplification of
the DHFR locus, which is immediately adjacent to the
hMSH3 gene [11].
These data provide us with an invaluable insight into the
aetiology of HNPCC tumours. The inheritance of a mutant
allele of a mismatch-repair gene predisposes individuals to
cancer of the colon and/or of other tissues (see [18,19] for
recent reviews), presumably through mutation of the
remaining wild-type allele and the associated conversion of
the heterozygous, mismatch-repair proficient cell to one
with a mutator phenotype. Assuming that mismatch repair
in humans is accomplished by a mechanism resembling
that proposed by Karran (Fig. 5; [10]), inactivation of
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Figure 4
(a) Binding of hMutSa and hMutSb to
substrates containing two-nucleotide loops.
(b) Duplex oligonucleotides used in (a); in
substrates A–H the region of interest is
highlighted in red. The figure shows that the
two mismatch-binding factors show
complementary preferences for various
substrates, such that oligonucleotide duplexes
bound weakly by hMutSa are generally bound
more strongly by hMutSb, and vice versa.
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AGCTTGGCTGCAGGTCGACGGATCCCCGGGAATT
TCGAACCGACGTCCAGCTGCCTAGGGGCCCTTAA
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Figure 5
Differential repair of mismatched DNA. Under normal circumstances,
base–base mispairs and loops are bound by hMutSa, which then recruits
the hMutLa complex consisting of hMLH1 and hPMS2 [20]. When GTBP
is absent, hMutSb compensates for the lack of hMutSa in loop repair, but
not in the repair of base–base mispairs. The scheme is similar to that
proposed in [10].
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hMSH2, hMLH1 and hPMS2 would cause a complete defi-
ciency in the repair of loops and base–base mismatches. In
contrast, mutations in either GTBP or hMSH3 would not
bring about a null mismatch-repair phenotype because of
the functional redundancy of these proteins in loop repair.
As the major difference between the mutator phenotypes
of cells deficient in hMSH2 and GTBP is the propensity of
the former to frameshift mutations, we infer that HNPCC
tumours arise from cells that are null for loop repair. Thus,
whereas only a single mutation would be required in the
case of the hMSH2, hMLH1 and hPMS2 genes, both hMSH3
and GTBP would have to be mutated to give rise to a
similar phenotype. As this event is statistically highly
improbable, we propose that mutations in hMSH3 and
GTBP will not be found in HNPCC tumours.
The Baculovirus technology described here should also
lead to rapid developments in the study of the MutL
homologs. To date, mutations in HNPCC tumours have
been linked with hMLH1, hPMS2 and hPMS1, although
only the former two, in the form of a hMutLa heterodimer
have been ascribed a role in mismatch repair [20]. The dif-
ficulties associated with the purification of the hMutLa
complex from human cells, as well as the study of the pos-
sible biological role of the putative hMutLb species, could
be readily overcome by overexpression of the recombinant
proteins in the Baculovirus system.
Materials and methods
Baculovirus expression vectors
The GTBP, hMSH3 and hMSH2 cDNA sequences were introduced
into pFastBacI vector (GIBCO-BRL) and the recombinant Bac-
uloviruses were obtained using the Bac-To-Bac system according to
the manufacturer’s (GIBCO–BRL) instructions. The detailed construc-
tion of these vectors will be described elsewhere.
Purification of the mismatch-binding factors
The purification of the recombinant hMutSa and hMutSb was per-
formed at 4 °C. Total extracts of 50 × 106 Sf9 cells co-infected with
Baculovirus vectors expressing either hMSH2 and GTBP, or hMSH2
and hMSH3, were prepared as described [21]. The extracts (12 mg,
6 mg ml–1 in HE buffer [15] containing 1 M NaCl) were passed through
a DEAE–Sepharose Fast Flow column (Pharmacia), diluted to 0.3 M
salt with 4 volumes of 0.05 M sodium phosphate (pH 7.0) and 2 mM b-
mercaptoethanol, and loaded onto a 1 ml Hi-Trap heparin–Sepharose
FPLC column (Pharmacia). The proteins were eluted with a 20 ml linear
gradient of 0.3–1 M NaCl in sodium phosphate (pH 7.0) and 2 mM b-
mercaptoethanol. The fractions containing the pure proteins were
pooled, dialyzed extensively against HE buffer containing 2 mM b-mer-
captoethanol, 10 % sucrose and 0.1 % PMSF, and stored in aliquots at
–80 °C. This procedure yielded 50 mg of protein.
Immunoprecipitation and band-shift experiments
Total extracts of Sf9 cells singly infected or co-infected with the Bac-
ulovirus vectors expressing hMSH2 or hMSH3 were immunoprecipi-
tated [22] with a rabbit polyclonal anti-hMSH2 antibody [1]. Sf9
extracts, immunoprecipitated proteins or purified proteins were loaded
on a denaturing 7.5 % SDS–polyacrylamide gel. Following elec-
trophoresis, the proteins were electroblotted onto a nitrocellulose
membrane and allowed to react with mouse polyclonal anti-hMSH3
antiserum. The bands were visualized by staining with goat anti-mouse
antibody conjugated with alkaline phosphatase (Promega). Band-shift
assays were performed as described in [21], except that 15 ng
(60 fmol) of the purified factors were used per lane, in the presence of
100 ng of non-specific competitor (poly(dI.dC); Pharmacia).
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